Man Group plc bought a new position in Nutrien Ltd. (NYSE:NTR - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 105,187 shares of the company's stock, valued at approximately $6,622,000.
A number of other hedge funds have also added to or reduced their stakes in the stock. Wellington Management Group LLP grew its stake in Nutrien by 440.2% during the fourth quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company's stock valued at $1,008,713,000 after acquiring an additional 13,313,817 shares in the last quarter. Deutsche Bank AG purchased a new stake in Nutrien in the 2nd quarter worth approximately $588,720,000. Norges Bank purchased a new stake in Nutrien in the 4th quarter worth approximately $412,635,000. The Manufacturers Life Insurance Company bought a new position in Nutrien in the 2nd quarter valued at $375,178,000. Finally, Canada Pension Plan Investment Board bought a new position in Nutrien in the 2nd quarter valued at $359,318,000. Hedge funds and other institutional investors own 63.10% of the company's stock.
More Nutrien News
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
- Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
- Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
- Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the company. Raymond James Financial upgraded Nutrien from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $74.00 to $90.00 in a research note on Tuesday, May 5th. UBS Group dropped their price target on Nutrien from $67.00 to $65.00 and set a "sell" rating for the company in a research report on Monday, May 11th. BNP Paribas Exane raised Nutrien from a "neutral" rating to an "outperform" rating and set a $80.00 price objective for the company in a report on Tuesday, July 28th. National Bank Financial decreased their price objective on shares of Nutrien from $76.00 to $74.00 and set an "outperform" rating on the stock in a research report on Monday, August 10th. Finally, Berenberg Bank set a $65.00 target price on shares of Nutrien and gave the company a "hold" rating in a research note on Wednesday, June 10th. Seventeen equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $81.58.
Get Our Latest Analysis on NTR
Nutrien Stock Up 0.8%
NTR opened at $73.64 on Friday. Nutrien Ltd. has a 12 month low of $53.03 and a 12 month high of $85.36. The company has a current ratio of 1.39, a quick ratio of 0.86 and a debt-to-equity ratio of 0.36. The business's 50-day moving average price is $67.33 and its 200-day moving average price is $70.56. The company has a market cap of $35.23 billion, a P/E ratio of 14.91, a P/E/G ratio of 0.78 and a beta of 0.61.
Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.70 by ($0.09). The firm had revenue of $10.81 billion during the quarter, compared to the consensus estimate of $10.44 billion. Nutrien had a return on equity of 8.88% and a net margin of 8.44%.Nutrien's revenue was up 3.6% on a year-over-year basis. During the same period last year, the business earned $2.65 EPS. On average, equities analysts expect that Nutrien Ltd. will post 4.71 EPS for the current year.
Nutrien Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 16th. Shareholders of record on Tuesday, September 29th will be issued a $0.55 dividend. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 dividend on an annualized basis and a yield of 3.0%. Nutrien's dividend payout ratio is 44.53%.
About Nutrien
(
Free Report)
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
See Also
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
